COMP <GO>
EWTX vs LEGN // 10Y YIELD & FRED MACRO BETA
Edgewise Therapeutics Inc. (NASDAQ) VS. Legend Biotech Corporation (NASDAQ) • 15-METRIC TALLY: EWTX 4
— LEGN 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: EWTX
LAST: $38.11 (-2.03%) • MKT CAP: $4.22B
macro-sensitivity
1.10
LAST: $21.10 (-2.45%) • MKT CAP: $4.21B
macro-sensitivity
1.04
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EWTX VS. LEGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EWTX | LEGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.90% | 9.90% | -41.80 | LEGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 21.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.41% | 2.21% | -5.62 | LEGN | /fcf-yield <GO> |
| Operating Margin | -16.20% | 13.90% | -30.10 | LEGN | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 10.90% | -10.90 | LEGN | /net-margins <GO> |
| Revenue Growth (YoY) | -1.10% | 9.90% | -11.00 | LEGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 3.74 | +22.26 | EWTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | LEGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 59.2 | -13.50 | LEGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.10 | 1.04 | +0.06 | EWTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.0x | 30.5x | -5.50 | EWTX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.22B | $4.21B | $17.9M | EWTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EWTX REV | LEGN REV | EWTX GROSS % | LEGN GROSS % | EWTX FCF | LEGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $535.9M | — | — | — | -$144.1M | — |
| FY 2024 | $444.7M | — | — | — | -$110.3M | — |
| FY 2023 | $320.2M | — | — | — | -$91.9M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EWTX // BETA 1.10
LEGN // BETA 1.04